Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005DE102004028862A1 3-Aminoindazole 3 aminoindazoles
12/29/2005DE102004027359A1 Pyridin-2-onverbindungen und deren Verwendung Pyridin-2-one compounds and use thereof
12/29/2005DE102004027358A1 Pyrimidinverbindungen und ihre Verwendung Pyrimidine compounds and their use
12/29/2005DE102004026703A1 Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen Process for the preparation of heterocyclically substituted in the 3-position of piperidine-2,6-diones
12/29/2005CA2570531A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2570365A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570363A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570264A1 3-aminoindazoles
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2570170A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2570065A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2569598A1 Novel cis-imidazolines
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/29/2005CA2568394A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609789A1 Ureido-pyrazole derivatives and their use as kinase inhibitors
12/28/2005EP1609788A1 Novel crystal of fluorobenzamide derivative
12/28/2005EP1609784A1 Process for the preparation of 4-(benzimidazolylmethylamino)-benzamidines
12/28/2005EP1609362A2 Non-systemic control of parasites
12/28/2005EP1608646A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
12/28/2005EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
12/28/2005EP1608643A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists
12/28/2005EP1608640A2 Urea derivatives having vanilloid receptor antagonist activity
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608630A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
12/28/2005EP1608629A1 Benzyl-pyridazinons as reverse transcriptase inhibitors
12/28/2005EP1608622A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers
12/28/2005EP1608620A1 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1497240A4 Non-heating clay composites for building materials
12/28/2005EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714081A Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
12/27/2005US6979741 Acetyl-CoA carboxylase inhibitors
12/27/2005US6979738 Quadruplex stabilizer
12/27/2005US6979693 Pyrazole derivatives-p38 MAP kinase inhibitors
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2354173C Novel process for the preparation of pyrazoles
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/27/2005CA2156287C Indolin-2-one derivative
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121129A1 Novel propenone derivatives containing aromatic rings, a maufacturing process thereof and a composition containing the same using as an antiinflammatory agent
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121125A1 Ether-linked heteroaryl compounds
12/22/2005WO2005121124A1 Complexes of e-2-methoxy-n-(3-{4-[3-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and methods of preparing same
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005121122A1 Imidazol-2-one compounds useful in the treatment of various disorders
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121105A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121099A1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121093A1 Lxr receptor modulators
12/22/2005WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005WO2005121090A1 Substituted piperidines that have antiangiogenic activity
12/22/2005WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/22/2005WO2005120510A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005WO2005120509A1 Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
12/22/2005WO2005120503A2 N-aryl piperidine compounds for inhibiting hiv infection
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005100340A3 Polycyclic pyridines as potassium ion channel modulators
12/22/2005WO2005097778A8 Tetrahydrobenzazepines as histamine h3 receptor ligands
12/22/2005WO2005082863A3 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
12/22/2005WO2005077931A3 Method for the production of 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
12/22/2005WO2005076854A3 Pyrimidinone compounds useful as kinase inhibitors
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005US20050283007 adamanolol; 1'-(adamantane-1-carbonyl)-[4,4']bipiperidinyl-1-carboxylic acid [2-hydroxy-3-3-(1H-indol-4-yloxy)-propyl]-isopropyl-amide;human epidermal growth factor receptor antagonist; alpha-helix mimetics of Sur-2 (supressor of Ras); anticarcinogenic agent; breast cancer
12/22/2005US20050283006 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282868 Substituted anthranilamides for controlling invertebrate pests
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 1080